The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer


Demir L., Somali I., Tarhan M. O., Erten C., ELLİDOKUZ H., Can A., ...More

JOURNAL OF BUON, vol.16, no.4, pp.682-688, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 4
  • Publication Date: 2011
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.682-688
  • Keywords: adjuvant treatment, colon cancer, efficacy, Nordic-FLOX regimen, toxicity, OXALIPLATIN-RELATED NEUROTOXICITY, METASTATIC COLORECTAL-CANCER, 1ST-LINE TREATMENT, RANDOMIZED-TRIAL, FOLINIC ACID, PHASE-III, FLUOROURACIL, LEUCOVORIN, LEVAMISOLE, CHEMOTHERAPY
  • Dokuz Eylül University Affiliated: Yes

Abstract

Purpose: To evaluate the toxicity and efficacy of oxaliplatin combined with the Nordic regimen of bolus 5-fluorouracil (5-FU) and leucovorin (LT) (Nordic-FLOX) as adjuvant treatment in stage III colon cancer patients.